The role of plasminogen activator ingibitor type 1 in the development of endothelial disfunction in patients with acute myocardial infarction and type 2 diabetes mellitus

Thumbnail Image

Date

2019

Authors

Кравчун, Павло Григорович
Бабаджан, Володимир Данилович
Мінухіна, Діана Валеріївна
Дунаєва, Інна Павлівна
Мінухін, Д.В.
Краснояружський, Андрій Григорович
Євтушенко, Д.О.
Minukhina, Diana
Babadzhan, Volodymyr
Kravchun, Pavlo H.

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

The high risk of vascular accidents is an incentive to study the pathogenetic mechanisms of thrombotic formation in type 2 diabetes. Plasminogen activator inhibitor type 1, which is a member of the superfamily of serine protease inhibitors and the main inhibitor of fibrinolysis in the plasminogen activator system, plays a key role in the pathogenesis of arterial and venous thrombosis and, therefore, contributes to the occurrence of thrombotic events.

Description

Keywords

Citation

The role of plasminogen activator ingibitor type 1 in the development of endothelial disfunction in patients with acute myocardial infarction and type 2 diabetes mellitus / D. V. Minukhina, V. D. Babadzhan, P. G. Kravchun, I. P. Dunaeva, D. V. Minukhin, A. G. Krasnoyaruzhskiy, D. A. Yevtushenko // Проблеми ендокринної патології. – 2019. – № 1 (67). – С. 30–37.

Endorsement

Review

Supplemented By

Referenced By